IBRX · Categories · Downgrades

IBRX - Analyst downgrades

ImmunityBio Inc. (IBRX) analyst downgrades - real-time wire coverage filtered to Downgrades only.

Recent Downgrades for IBRX

• 1125d
  ImmunityBio downgraded by Piper Sandler with a new price target

  Piper Sandler downgraded ImmunityBio from Overweight to Neutral and set a new price target of $4.00 from $10.00 previously

Other IBRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings